Citius Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Citius Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q2 2024.
  • Citius Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 181M shares, a 13.8% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 181M +21.9M +13.8% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 159M +12.7M +8.7% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 159M +12.8M +8.72% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 159M +12.6M +8.65% Sep 30, 2023 10-Q 2024-08-12
Q2 2023 159M +12.7M +8.71% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 146M +228K +0.16% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 146M +182K +0.12% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 146M +232K +0.16% Sep 30, 2022 10-K 2023-12-29
Q2 2022 146M +150K +0.1% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 146M +11.4M +8.48% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 146M +90.5M +163% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 146M +90.4M +163% Sep 30, 2021 10-K 2022-12-22
Q2 2021 146M +99.7M +215% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 135M +96.6M +254% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 55.6M +25.4M +84.2% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 55.6M +26.6M +92.1% Sep 30, 2020 10-K 2021-12-15
Q2 2020 46.3M +24.2M +110% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 38.1M +19.4M +104% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 30.2M +12.4M +69.5% Dec 31, 2019 10-Q 2020-02-13
Q3 2019 28.9M +12.7M +78.6% Sep 30, 2019 10-K 2020-12-16
Q2 2019 22.1M +11.4M +107% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 18.6M +7.98M +74.8% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 17.8M +7.82M +78.4% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 16.2M +7.85M +94.1% Sep 30, 2018 10-K 2019-12-16
Q2 2018 10.7M +5.62M +111% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 10.7M -64.8M -85.9% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 9.98M -64.1M -86.5% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 8.35M +3.47M +71.2% Sep 30, 2017 10-K 2019-12-16
Q2 2017 5.06M -68M -93.1% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 75.5M +4.37M +6.14% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 74.1M +39.4M +114% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 4.88M -29.2M -85.7% Sep 30, 2016 10-K 2017-12-13
Q2 2016 73M +39.8M +120% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 71.1M +39.6M +125% Mar 31, 2016 10-Q 2016-05-20
Q4 2015 34.7M +3.62M +11.6% Dec 31, 2015 10-Q 2016-02-12
Q3 2015 34.1M +21.1M +162% Sep 30, 2015 10-K 2016-12-23
Q2 2015 33.2M +15.2M +84.6% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 31.6M +13.6M +75.4% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 31.1M +13.3M +75% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 13M -5M -27.8% Sep 30, 2014 10-K 2016-12-23
Q2 2014 18M 0 0% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 18M 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 17.8M -243K -1.35% Dec 31, 2013 10-KT 2014-12-29
Q3 2013 18M 0 0% Sep 30, 2013 10-Q 2014-08-14
Q2 2013 18M 0 0% Jun 30, 2013 10-Q 2013-09-18
Q1 2013 18M 0 0% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 18M 0 0% Dec 31, 2012 10-Q 2013-02-08
Q3 2012 18M 0 0% Sep 30, 2012 10-K 2014-02-06
Q2 2012 18M 0 0% Jun 30, 2012 10-Q 2012-08-17
Q1 2012 18M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 18M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 18M 0 0% Sep 30, 2011 10-K 2013-01-15
Q2 2011 18M Jun 30, 2011 10-Q 2011-08-26
Q3 2010 18M Sep 30, 2010 10-K 2012-01-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.